CONSHOHOCKEN, Pa., Oct. 26, 2016 /PRNewswire/ -- Quaker
Chemical Corporation (NYSE: KWR) today announced net sales of $190.4 million in the third quarter
of 2016, a 1% increase compared to $189.2 million in the third quarter of 2015, as a 2% growth from
organic volume and a 2% increase from acquisitions outpaced a 2% negative impact from foreign currency translation and an
approximate 1% decline in selling price and product mix. While gross margins declined somewhat quarter-over-quarter, the
Company was able to grow its operating income by 14% to $21.3 million in the third quarter of 2016
compared to $18.7 million in the third quarter of 2015. The Company achieved this operating
income growth due to continued discipline in managing labor-related costs in its selling, general and administrative expenses
("SG&A") and lower impacts from certain uncommon transaction-related expenses quarter-over-quarter. Excluding these
transaction-related costs, the Company's operating income drove a 6% increase in its adjusted EBITDA to $28.3 million in the third quarter of 2016 compared to $26.8 million in the prior
year quarter.
The Company's earnings per diluted share increased 12% to $1.21 for the current quarter compared
to $1.08 in the third quarter of 2015, with non-GAAP earnings per diluted share increasing 5% to
$1.25 in the current quarter compared to $1.19 in the third quarter
of 2015. This growth in both reported and non-GAAP earnings per diluted share was achieved despite a negative impact from
foreign exchange of approximately 3%, or $0.04 per diluted share, and a higher effective tax rate
of 28.3% compared to 24.4% in the prior year quarter. The increase in the Company's effective tax rate is due to the timing
of the recertification of a concessionary tax rate in one of its subsidiaries, which was available to the Company throughout 2015
and which is expected to be received in the fourth quarter of 2016, resulting in a full year cumulative adjustment. The
Company's strong operating earnings drove net operating cash flow of $17.0 million in the third
quarter of 2016 and $53.0 million year-to-date, a 4% increase compared to $50.8 million in the first nine months of 2015.
Michael F. Barry, Chairman, Chief Executive Officer and President commented, "We are pleased
with our third quarter results, despite a challenging environment and continued foreign exchange headwinds. We were
able to grow our revenue both organically by 2% and from acquisitions by 2%. While our gross margins declined somewhat as
raw material prices increased, we were more than able to offset the decline with savings realized from our previously announced
restructuring and other cost streamlining initiatives which enabled our adjusted EBITDA margin to increase to nearly 15%.
This performance was achieved despite foreign exchange headwinds, which negatively impacted our top and bottom lines by 2% and
3%, respectively. For the fourth quarter, we expect our gross margin to remain at a similar level as the third quarter
and we believe our ability to take market share and leverage past acquisitions, as well as our cost saving efforts, will continue
to help offset market and foreign exchange challenges. In summary, our fourth quarter and full year 2016 forecast continues
to indicate growth in both the top and bottom lines and we still expect to increase non-GAAP earnings and adjusted EBITDA for the
seventh consecutive year."
Third Quarter of 2016 Summary
Net sales in the third quarter of 2016 were $190.4 million compared to $189.2 million in the third quarter of 2015. The $1.2 million, or 1%,
increase in net sales was primarily due to a 2% increase in organic volumes and a 2% increase from acquisitions, partially offset
by the negative impact of foreign currency translation of $3.7 million, or 2% and an approximate 1%
decline in selling price and product mix quarter-over-quarter.
Gross profit in the third quarter of 2016 decreased approximately $0.6 million, or 1%, from the
third quarter of 2015, primarily due to slightly lower gross margin of 37.2% in the third quarter of 2016 compared to 37.7% in
the prior year quarter on changes in raw material costs and product mix, partially offset by the increase in sales volumes, noted
above.
SG&A decreased $3.2 million during the third quarter of 2016, primarily due to the impact of
cost savings efforts, including the 2015 global restructuring program, and a decrease in transaction-related expenses.
During the third quarters of 2016 and 2015, the Company incurred $1.2 million and $2.8 million, respectively, for certain uncommon transaction-related costs in connection with the execution of,
and diligence on, acquisition candidates. In addition, overall labor–related costs were relatively flat
quarter-over-quarter as annual compensation increases and incremental costs associated with the Company's July 2015 Verkol acquisition were offset by certain cost savings efforts, noted above. Related to the
restructuring program, the Company did not incur any additional restructuring expenses in the third quarter of 2016 and continues
to execute the program as planned. The Company continues to project pre-tax cost savings as a result of this program to
approximate $3 million for 2016, realized mainly over the second half of the year, and $6 million annually in subsequent years. In addition, the Company still expects to substantially complete
this program during 2016.
Operating income in the third quarter of 2016 was $21.3 million, which increased 14% compared to
$18.7 million in the third quarter of 2015. The increase in operating income was primarily
due to the increase in sales volumes and the decrease in SG&A quarter-over-quarter, partially offset by the decline in gross
margin, noted above.
Other income was $0.5 million in the third quarter of 2016 compared to $0.2 million in the third quarter of 2015. The increase in other income was primarily driven by foreign
currency transaction gains realized in the third quarter of 2016 compared to foreign currency transaction losses in the third
quarter of 2015.
Interest expense was relatively consistent on comparable average borrowings outstanding in the third quarter of 2016 compared
to the third quarter of 2015. Interest income was $0.1 million higher in the third quarter of
2016 compared to the third quarter of 2015, primarily due to an increase in the level of the Company's invested cash.
The Company's effective tax rates for the third quarters of 2016 and 2015 were 28.3% and 24.4%, respectively. The
increase in the third quarter of 2016 effective tax rate was primarily due to the Company recording earnings in one of its
subsidiaries at a statutory tax rate of 25% while it awaits the recertification of a concessionary 15% tax rate, which was
available to the Company during the third quarter of 2015. The Company still expects to receive this recertification and to
record the full year cumulative benefit of the reduced rate in the fourth quarter of 2016.
Equity in net income of associated companies ("equity income") increased $0.1 million in the
third quarter of 2016 compared to the third quarter of 2015, primarily due to higher earnings from the Company's interest in a
captive insurance company in the third quarter of 2016 compared to the prior year quarter.
Net income attributable to noncontrolling interest decreased $0.1 million in the third quarter
of 2016 compared to the prior year quarter, primarily due to lower earnings attributable to the Company's India affiliate.
Changes in foreign exchange rates negatively impacted the Company's third quarter of 2016 net income by approximately 3%, or
$0.04 per diluted share.
Year-to-Date 2016 Summary
Net sales in the first nine months of 2016 were $555.4 million compared to $554.3 million in the first nine months of 2015. The slight increase in net sales was primarily the
result of a 5% increase in volumes, including acquisitions, largely offset by the negative impact of foreign currency translation
of $17.0 million, or 3%, and declines in selling price and product mix of 1%.
Gross profit in the first nine months of 2016 increased $1.6 million, or 1%, from the first nine
months of 2015, primarily driven by the increase in sales volumes, noted above, on relatively consistent gross margins of 37.8%
in the first nine months of 2016 compared to 37.6% in the first nine months of 2015.
SG&A decreased $3.0 million during the first nine months of 2016, primarily due to a
decrease from foreign currency translation, lower uncommon transaction-related expenses and the cost savings efforts, noted
above, which more than offset higher overall labor-related costs, including incremental costs associated with the Company's
acquisition of Verkol.
Operating income in the first nine months of 2016 was $62.7 million, which increased 8% compared
to $58.0 million in the first nine months of 2015. The increase in operating income during
the first nine months of 2016 was primarily driven by higher sales volumes on consistent gross margin levels and the decrease in
SG&A year-over-year, noted above.
Other income was $1.5 million in the first nine months of 2016 compared to other expense of
$0.1 million in the first nine months of 2015. The increase in other income was primarily
driven by foreign currency transaction gains realized in the first nine months of 2016 compared to foreign currency transaction
losses in the first nine months of 2015.
Interest expense was $0.3 million higher in the first nine months of 2016 compared to the first
nine months of 2015, primarily due to increased average borrowings outstanding during the first nine months of 2016 as a result
of the Verkol acquisition. Interest income was $0.3 million higher in the first nine months
of 2016 compared to the first nine months of 2015, primarily due to an increase in the level of the Company's invested cash and
increased interest received on certain tax-related credits during the first nine months of 2016.
The Company's effective tax rates for the first nine months of 2016 and 2015 were 31.0% and 27.3%, respectively. The
increase in the first nine months of 2016 effective tax rate was primarily due to the Company recording earnings in one of its
subsidiaries at a statutory tax rate of 25% while it awaits the recertification of a concessionary 15% tax rate, which was
available to the Company during the first nine months of 2015. However, the Company still expects to receive its
recertification during the fourth quarter of 2016, as noted above, and estimates its full year 2016 effective tax rate will
decrease to approximately 28% to 30%.
Equity income increased $2.1 million in the first nine months of 2016 compared to the first nine
months of 2015. The increase in equity income was primarily due to a smaller currency conversion charge recorded at the
Company's Venezuela affiliate during the first nine months of 2016 compared to the first nine
months of 2015, related to changes in Venezuela's foreign exchange markets and currency controls
in both periods. In addition, equity income includes earnings from the Company's interest in a captive insurance company,
which was lower in the first nine months of 2016 compared to the first nine months of 2015.
The Company had a $0.1 million increase in net income attributable to noncontrolling interest in
the first nine months of 2016 compared to the first nine months of 2015, primarily due to stronger performance at its
India affiliate.
Changes in foreign exchange rates, excluding the currency conversion impacts of the Venezuelan bolivar fuerte, noted above,
negatively impacted the Company's first nine months of 2016 net income by approximately 3%, or $0.11 per diluted share.
Balance Sheet and Cash Flow Items
The Company's net operating cash flow of $17.0 million in the third quarter of 2016 increased
its year-to-date net operating cash flow to $53.0 million, a 4% increase compared to $50.8 million in the first nine months of 2015. The increase was driven by the Company's solid operating
performance and lower cash invested in its working capital. In addition, the Company paid approximately $4.6 million in cash dividends during the third quarter of 2016, increasing its total dividends paid to
$13.1 million in the first nine months of 2016. The Company also repurchased approximately
84,000 shares of its common stock for $5.9 million in the first nine months of 2016. Overall,
the Company's liquidity and balance sheet remain strong, as its cash position exceeded its debt at September 30, 2016 and the Company's consolidated leverage ratio continued to be less than one times
EBITDA.
Non-GAAP Measures
Included in this public release are two non-GAAP (unaudited) financial measures: non-GAAP earnings per diluted share and
adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they
enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance
of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that
are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes
only and should not be considered a substitute for the financial information presented in accordance with GAAP. The
following tables reconcile non-GAAP earnings per diluted share (unaudited) and adjusted EBITDA (unaudited) to their most directly
comparable GAAP (unaudited) financial measures:
|
Three Months Ended
September 30,
|
|
Nine Months Ended
September 30,
|
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
GAAP earnings per diluted share attributable to Quaker Chemical Corporation
common shareholders
|
$ 1.21
|
|
$ 1.08
|
|
$ 3.32
|
|
$ 2.98
|
|
Equity income in a captive insurance company per diluted share
|
(0.04)
|
|
(0.04)
|
|
(0.07)
|
|
(0.09)
|
|
Certain uncommon transaction-related expenses per diluted share
|
0.08
|
|
0.15
|
|
0.08
|
|
0.15
|
|
U.S. customer bankruptcies per diluted share
|
—
|
|
0.00
|
|
—
|
|
0.01
|
|
Cost streamlining initiatives per diluted share
|
—
|
|
—
|
|
—
|
|
0.01
|
|
Currency conversion impact of the Venezuelan bolivar fuerte per diluted
share
|
—
|
|
—
|
|
0.01
|
|
0.21
|
|
Non-GAAP earnings per diluted share
|
$ 1.25
|
|
$ 1.19
|
|
$ 3.34
|
|
$ 3.27
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30,
|
|
Nine Months Ended
September 30,
|
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
Net income attributable to Quaker Chemical Corporation
|
$ 16,008
|
|
$ 14,371
|
|
$ 43,969
|
|
$ 39,787
|
|
Depreciation and amortization
|
4,868
|
|
4,863
|
|
14,788
|
|
14,227
|
|
Interest expense
|
758
|
|
697
|
|
2,226
|
|
1,891
|
|
Taxes on income before equity in net income of associated
companies
|
6,121
|
|
4,541
|
|
19,664
|
|
15,624
|
|
Equity income in a captive insurance company
|
(597)
|
|
(526)
|
|
(952)
|
|
(1,221)
|
|
Certain uncommon transaction-related expenses
|
1,157
|
|
2,813
|
|
1,157
|
|
2,813
|
|
U.S. customer bankruptcies
|
—
|
|
68
|
|
—
|
|
179
|
|
Cost streamlining initiatives
|
—
|
|
—
|
|
—
|
|
173
|
|
Currency conversion impact of the Venezuelan bolivar fuerte
|
—
|
|
—
|
|
88
|
|
2,806
|
|
Adjusted EBITDA
|
$ 28,315
|
|
$ 26,827
|
|
$ 80,940
|
|
$ 76,279
|
|
Adjusted EBITDA margin (%)
|
14.9%
|
|
14.2%
|
|
14.6%
|
|
13.8%
|
|
|
|
|
|
|
|
|
|
|
|
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties
that could cause actual results to differ materially from those projected in such statements. A major risk is that demand
for the Company's products and services is largely derived from the demand for its customers' products, which subjects the
Company to uncertainties related to downturns in a customer's business and unanticipated customer production shutdowns.
Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer
financial stability, worldwide economic and political conditions, foreign currency fluctuations, significant changes in
applicable tax rates and regulations, future terrorist attacks and other acts of violence. Other factors could also
adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This
discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced, Quaker Chemical's investor conference call to discuss the third quarter of 2016 results is scheduled
for October 27, 2016 at 8:30 a.m. (ET). A live webcast of the
conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at
http://www.quakerchem.com. You can also access the
conference call by dialing 877-269-7756.
About Quaker
Quaker Chemical is a leading global provider of process fluids, chemical specialties, and technical expertise
to a wide range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and
others. For nearly 100 years, Quaker has helped customers around the world achieve production efficiency, improve product
quality, and lower costs through a combination of innovative technology, process knowledge, and customized services.
Headquartered in Conshohocken, Pennsylvania USA, Quaker serves businesses worldwide with
a network of dedicated and experienced professionals whose mission is to make a difference.
|
Quaker Chemical Corporation
|
|
|
Condensed Consolidated Statements of Income
|
|
|
(Dollars in thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
Three Months Ended September 30
|
|
Nine Months Ended September 30
|
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
$ 190,428
|
|
$ 189,224
|
|
$ 555,420
|
|
$ 554,280
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
119,649
|
|
117,895
|
|
345,531
|
|
346,006
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
70,779
|
|
71,329
|
|
209,889
|
|
208,274
|
|
|
%
|
37.2%
|
|
37.7%
|
|
37.8%
|
|
37.6%
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
49,440
|
|
52,601
|
|
147,223
|
|
150,237
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
21,339
|
|
18,728
|
|
62,666
|
|
58,037
|
|
|
%
|
11.2%
|
|
9.9%
|
|
11.3%
|
|
10.5%
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense), net
|
514
|
|
185
|
|
1,491
|
|
(97)
|
|
|
Interest expense
|
(758)
|
|
(697)
|
|
(2,226)
|
|
(1,891)
|
|
|
Interest income
|
551
|
|
422
|
|
1,444
|
|
1,117
|
|
|
Income before taxes and equity in net income of associated
companies
|
21,646
|
|
18,638
|
|
63,375
|
|
57,166
|
|
|
|
|
|
|
|
|
|
|
|
Taxes on income before equity in net income of associated
companies
|
6,121
|
|
4,541
|
|
19,664
|
|
15,624
|
|
|
Income before equity in net income of associated companies
|
15,525
|
|
14,097
|
|
43,711
|
|
41,542
|
|
|
|
|
|
|
|
|
|
|
|
Equity in net income (loss) of associated companies
|
826
|
|
738
|
|
1,389
|
|
(688)
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
16,351
|
|
14,835
|
|
45,100
|
|
40,854
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interest
|
343
|
|
464
|
|
1,131
|
|
1,067
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Quaker Chemical Corporation
|
$ 16,008
|
|
$ 14,371
|
|
$ 43,969
|
|
$ 39,787
|
|
|
%
|
8.4%
|
|
7.6%
|
|
7.9%
|
|
7.2%
|
|
|
|
|
|
|
|
|
|
|
|
Share and per share data:
|
|
|
|
|
|
|
|
|
|
Basic weighted average common shares outstanding
|
13,143,884
|
|
13,209,119
|
|
13,128,996
|
|
13,206,122
|
|
|
Diluted weighted average common shares outstanding
|
13,173,844
|
|
13,222,452
|
|
13,147,825
|
|
13,222,303
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Quaker Chemical Corporation Common Shareholders
- basic
|
$
1.21
|
|
$
1.08
|
|
$
3.32
|
|
$
2.99
|
|
|
Net income attributable to Quaker Chemical Corporation Common Shareholders
- diluted
|
$
1.21
|
|
$
1.08
|
|
$
3.32
|
|
$
2.98
|
|
|
Quaker Chemical Corporation
|
|
Condensed Consolidated Balance Sheets
|
|
(Dollars in thousands, except par value and share amounts)
|
|
|
|
|
|
(Unaudited)
|
|
September 30,
|
|
December 31,
|
|
2016
|
|
2015
|
|
ASSETS
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
Cash and cash equivalents
|
$ 99,024
|
|
$ 81,053
|
|
Accounts receivable, net
|
193,805
|
|
188,297
|
|
Inventories, net
|
79,660
|
|
75,099
|
|
Prepaid expenses and other current assets
|
21,624
|
|
21,404
|
|
Total current assets
|
394,113
|
|
365,853
|
|
Property, plant and equipment, net
|
83,865
|
|
87,619
|
|
Goodwill
|
79,324
|
|
79,111
|
|
Other intangible assets, net
|
69,789
|
|
73,287
|
|
Investments in associated companies
|
23,448
|
|
20,354
|
|
Non-current deferred tax assets
|
17,621
|
|
23,468
|
|
Other assets
|
29,311
|
|
32,218
|
|
Total assets
|
$ 697,471
|
|
$ 681,910
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
Short-term borrowings and current portion of long-term
debt
|
$
730
|
|
$
662
|
|
Accounts and other payables
|
78,579
|
|
71,543
|
|
Accrued compensation
|
17,687
|
|
19,166
|
|
Accrued restructuring
|
2,233
|
|
6,303
|
|
Other current liabilities
|
25,532
|
|
26,881
|
|
Total current liabilities
|
124,761
|
|
124,555
|
|
Long-term debt
|
75,607
|
|
81,439
|
|
Non-current deferred tax liabilities
|
11,776
|
|
11,400
|
|
Other non-current liabilities
|
71,629
|
|
83,273
|
|
Total liabilities
|
283,773
|
|
300,667
|
|
|
|
|
|
Equity
|
|
|
|
|
Common stock, $1 par value; authorized 30,000,000 shares; issued and
outstanding 2016 - 13,257,066 shares; 2015 - 13,288,113 shares
|
13,257
|
|
13,288
|
|
Capital in excess of par value
|
111,453
|
|
106,333
|
|
Retained earnings
|
351,560
|
|
326,740
|
|
Accumulated other comprehensive loss
|
(72,027)
|
|
(73,316)
|
|
Total Quaker shareholders' equity
|
404,243
|
|
373,045
|
|
Noncontrolling interest
|
9,455
|
|
8,198
|
|
Total equity
|
413,698
|
|
381,243
|
|
Total liabilities and equity
|
$ 697,471
|
|
$ 681,910
|
|
Quaker Chemical Corporation
|
|
Condensed Consolidated Statements of Cash Flows
|
|
(Dollars in thousands)
|
|
|
|
|
|
(Unaudited)
|
|
Nine Months Ended September 30,
|
|
2016
|
|
2015
|
|
Cash flows from operating activities
|
|
|
|
|
Net income
|
$ 45,100
|
|
$ 40,854
|
|
Adjustments to reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
Depreciation
|
9,469
|
|
9,229
|
|
Amortization
|
5,319
|
|
4,998
|
|
Equity in undistributed (earnings) losses of associated companies, net of
dividends
|
(1,314)
|
|
1,362
|
|
Deferred compensation and other, net
|
3,083
|
|
(551)
|
|
Stock-based compensation
|
4,942
|
|
4,500
|
|
Loss (gain) on disposal of property, plant, equipment and other
assets
|
44
|
|
(95)
|
|
Insurance settlement realized
|
(809)
|
|
(549)
|
|
Pension and other postretirement benefits
|
(3,373)
|
|
2,204
|
|
(Decrease) increase in cash from changes in current assets and current
liabilities, net of acquisitions:
|
|
|
|
|
Accounts receivable
|
(5,926)
|
|
(4,039)
|
|
Inventories
|
(3,741)
|
|
(1,028)
|
|
Prepaid expenses and other current assets
|
(868)
|
|
(3,545)
|
|
Accounts payable and accrued liabilities
|
5,245
|
|
(2,521)
|
|
Change in restructuring liabilities
|
(4,194)
|
|
-
|
|
Net cash provided by operating activities
|
52,977
|
|
50,819
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
Investments in property, plant and equipment
|
(6,311)
|
|
(6,115)
|
|
Payments related to acquisitions, net of cash acquired
|
(3,244)
|
|
(23,990)
|
|
Proceeds from disposition of assets
|
54
|
|
130
|
|
Insurance settlement interest earned
|
24
|
|
28
|
|
Change in restricted cash, net
|
785
|
|
521
|
|
Net cash used in investing activities
|
(8,692)
|
|
(29,426)
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
Proceeds from long-term debt
|
-
|
|
30,668
|
|
Repayments of long-term debt
|
(6,842)
|
|
(304)
|
|
Dividends paid
|
(13,052)
|
|
(12,257)
|
|
Stock options exercised, other
|
64
|
|
947
|
|
Payments for repurchase of common stock
|
(5,859)
|
|
(4,989)
|
|
Excess tax benefit related to stock option exercises
|
167
|
|
400
|
|
Net cash (used in) provided by financing activities
|
(25,522)
|
|
14,465
|
|
|
|
|
|
Effect of foreign exchange rate changes on cash
|
(792)
|
|
(4,434)
|
|
Net increase in cash and cash equivalents
|
17,971
|
|
31,424
|
|
Cash and cash equivalents at the beginning of the period
|
81,053
|
|
64,731
|
|
Cash and cash equivalents at the end of the period
|
$ 99,024
|
|
$ 96,155
|
Logo - http://photos.prnewswire.com/prnh/20120910/PH70044LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quaker-chemical-announces-third-quarter-2016-results-300351903.html
SOURCE Quaker Chemical Corporation